Jose Maria Gatell
Overview
Explore the profile of Jose Maria Gatell including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
48
Citations
434
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Xufre C, Gonzalez T, Leal L, Trubey C, Lifson J, Gatell J, et al.
Front Virol
. 2022 Aug;
2.
PMID: 35967461
We described a novel HIV autologous isolation method based in coculturing macrophages and CD4T-cell-enriched fractions from peripheral blood collected from antiretroviral-treated (ART) HIV patients. This method allows the isolation of...
2.
Saumoy M, Sanchez-Quesada J, Assoumou L, Gatell J, Gonzalez-Cordon A, Guaraldi G, et al.
J Antimicrob Chemother
. 2022 Apr;
77(7):1980-1988.
PMID: 35411401
Background: The aim of this study was to investigate whether switching from a ritonavir-boosted PI-based regimen to a dolutegravir-based regimen improved the atherogenic properties of LDL particles in patients with...
3.
Leal L, Couto E, Sanchez-Palomino S, Climent N, Fernandez I, Miralles L, et al.
Front Immunol
. 2021 Dec;
12:767370.
PMID: 34858423
Introduction: Functional cure has been proposed as an alternative to lifelong antiretroviral therapy and therapeutic vaccines represent one of the most promising approaches. Materials And Methods: We conducted a double-blind...
4.
Lyonnais S, Sadiq S, Lorca-Oro C, Dufau L, Nieto-Marquez S, Escriba T, et al.
Viruses
. 2021 Nov;
13(11).
PMID: 34835118
A growing number of studies indicate that mRNAs and long ncRNAs can affect protein populations by assembling dynamic ribonucleoprotein (RNP) granules. These phase-separated molecular 'sponges', stabilized by quinary (transient and...
5.
Raben D, Sullivan A, Mocroft A, Kutsyna G, Hadziosmanovic V, Vassilenko A, et al.
PLoS One
. 2019 Aug;
14(8):e0220108.
PMID: 31408476
Background: It is cost-effective to perform an HIV test in people with specific indicator conditions (IC) with an undiagnosed HIV prevalence of at least 0.1%. Our aim was to determine...
6.
Tort O, Escriba T, Egana-Gorrono L, de Lazzari E, Cofan M, Fernandez E, et al.
J Lipid Res
. 2018 Sep;
59(11):2108-2115.
PMID: 30213800
Cholesterol efflux (CE) capacity has been inversely associated with atherosclerosis and may provide an insight on inflammation occurring in human immunodeficiency virus (HIV) individuals. We address this by studying CE...
7.
Climent N, Garcia I, Marradi M, Chiodo F, Miralles L, Maleno M, et al.
Nanomedicine
. 2017 Nov;
14(2):339-351.
PMID: 29157976
Gold nanoparticles (GNPs) decorated with glycans ameliorate dendritic cells (DC) uptake, antigen-presentation and T-cells cross-talk, which are important aspects in vaccine design. GNPs allow for high antigen loading, DC targeting,...
8.
Tort O, Sanchez-Palomino S, Escriba T, Calvo C, Gonzalez T, Gatell J, et al.
AIDS
. 2016 Oct;
30(17):2733-2735.
PMID: 27782969
No abstract available.
9.
Gomara M, Perez-Pomeda I, Gatell J, Sanchez-Merino V, Yuste E, Haro I
Nanomedicine
. 2016 Aug;
13(2):601-609.
PMID: 27565689
The work reports the design and synthesis of a chimeric peptide that is composed of the peptide sequences of two entry inhibitors which target different sites of HIV-1 gp41. The...
10.
Leal L, Torres B, Leon A, Lucero C, Inciarte A, Diaz-Brito V, et al.
AIDS Res Hum Retroviruses
. 2016 Jul;
32(10-11):1016-1021.
PMID: 27457508
Objective: To better target our current prevention strategies, we assessed factors associated with HIV seroconversion in individuals attending a specialized center after a risk exposure. Materials And Methods: We studied...